RETRACTION: MicroRNA-95 Knockdown Inhibits Epithelial-mesenchymal Transition and Cancer Stem Cell Phenotype in Gastric Cancer Cells through MAPK Pathway by Upregulating DUSP5

被引:0
|
作者
Du, M.
Zhuang, Y.
Tan, P.
Yu, Z.
Zhang, X.
Wang, A.
机构
关键词
D O I
10.1002/jcp.31392
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
RETRACTION: M. Du, Y. Zhuang, P. Tan, Z. Yu, X. Zhang, A. Wang, "MicroRNA-95 Knockdown Inhibits Epithelial-mesenchymal Transition and Cancer Stem Cell Phenotype in Gastric Cancer Cells through MAPK Pathway by Upregulating DUSP5," Journal of Cellular Physiology 235, no. 2 (2020): 944-956, . The above article, published online on 15 July 2019 in Wiley Online Library (), has been retracted by agreement between the journal Editor-in-Chief, Robert Heath; and Wiley Periodicals LLC. The retraction has been agreed due to concerns raised by third parties on the data presented in the article. Specifically, the article makes use of unverifiable/unknown and/or contaminated cell lines. Additionally, the description of experimental methods is insufficient and relevant supporting data is unavailable, making the foundation of the study not comprehensible and/or reproducible to readers. Accordingly, the conclusions of this article are considered invalid by the editors. The authors have been informed of the decision of retraction but unavailable for a final confirmation.
引用
收藏
页数:1
相关论文
共 50 条
  • [1] microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5
    Du, Mei
    Zhuang, Yuan
    Tan, Peng
    Yu, Zongbu
    Zhang, Xiutian
    Wang, Aihua
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (02) : 944 - 956
  • [2] Epithelial-mesenchymal transition and gastric cancer stem cell
    Xia, Pu
    Xu, Xiao-Yan
    TUMOR BIOLOGY, 2017, 39 (05)
  • [3] MicroRNA control of epithelial-mesenchymal transition in cancer stem cells
    Hao, Jin
    Zhang, Yueling
    Deng, Mengzhao
    Ye, Rui
    Zhao, Sen
    Wang, Yating
    Li, Juan
    Zhao, Zhihe
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (05) : 1019 - 1027
  • [4] MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells
    Guan, Bing
    Mu, Lijun
    Zhang, Linlin
    Wang, Ke
    Tian, Juanhua
    Xu, Shan
    Wang, Xinyang
    He, Dalin
    Du, Yuefeng
    ONCOLOGY LETTERS, 2018, 16 (02) : 1821 - 1826
  • [5] HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway
    Yang, Shi-wei
    Zhang, Zhi-gang
    Hao, Ying-xue
    Zhao, Yong-liang
    Qian, Feng
    Shi, Yan
    Li, Ping-ang
    Liu, Chun-yang
    Yu, Pei-wu
    ONCOTARGET, 2017, 8 (06) : 9535 - 9545
  • [6] Zyxin inhibits the epithelial-mesenchymal transition process in gastric cancer by upregulating SIRT1
    Lou, Jing
    Geng, Sha
    He, Wei
    Liu, Song-Bai
    Shi, Xinghong
    Chang, Ying
    Han, Shiyuan
    Qian, Panting
    Amin, Hesham M.
    Song, Yao-Hua
    Li, Yangxin
    Zhou, Jin
    MEDCOMM, 2023, 4 (05):
  • [7] Knockdown of AGGF1 inhibits the invasion and migration of gastric cancer via epithelial-mesenchymal transition through Wnt/-catenin pathway
    Yao, Han-Hui
    Zhao, Ya-Jun
    He, Yi-Fu
    Huang, Da-Bing
    Wang, Wei
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [8] MicroRNA-18a induces epithelial-mesenchymal transition like cancer stem cell phenotype via regulating RKIP pathway in pancreatic cancer
    Kang, Honggang
    Ma, Dan
    Zhang, Jing
    Zhao, Jun
    Yang, Mengxiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (07)
  • [9] DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition
    Kang, Xing
    Li, Minhuan
    Zhu, Hao
    Lu, Xiaofeng
    Miao, Ji
    Du, Shangce
    Xia, Xuefeng
    Guan, Wenxian
    ONCOTARGET, 2017, 8 (55) : 94028 - 94039
  • [10] Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF-B Pathway in Gastric Cancer Cells
    Li, Jinxia
    Dai, Chunyan
    Shen, Li
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019